Downloadable PowerPoint Slideset

Share

Program Content

Activities

  • Multiple Myeloma Update
    An Update in Diagnosis, Prognosis, and Treatment of Multiple Myeloma – for the Treating Oncologist
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 01, 2023

  • Immuno-Oncology Multiple Myeloma
    Immuno-Oncology in Myeloma: New Indications and Approvals
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 01, 2023

  • New Opportunities: Myeloma
    New Therapeutic Opportunities in Myeloma
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 01, 2023

Faculty

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Chair, Myeloma, Amyloidosis and Dysproteinemia Group
Research Chair, Division of Hematology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Joseph Mikhael, MD, MEd, FRCPC, FACP

Professor
Applied Cancer Research and Drug Discovery 
Translational Genomics Research Institute 
Phoenix, Arizona
Chief Medical Officer
International Myeloma Foundation 
HonorHealth Research Institute 
Scottsdale, Arizona

cover img faculity

Noopur Raje, MD

Professor of Medicine
Harvard Medical School
Director, Center for Multiple Myeloma
Massachusetts General Hospital
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from AbbVie Inc., Bristol Myers Squibb, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., Karyopharm Therapeutics, Legend Biotech USA Inc., and Pfizer Inc.

AbbVie Inc.

Bristol Myers Squibb

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Karyopharm Therapeutics Inc.

Legend Biotech USA Inc.

Pfizer, Inc.